Arvinas Inc.

91 articles with Arvinas Inc.

• Arvinas To Present Data At The 2016 AACR Annual Meeting

  4/14/2016

• Arvinas Appoints Angela Shen As Chief Medical Officer

  3/2/2016

• Arvinas Presents Data At The 2015 American Society of Hematology Annual Meeting

  12/3/2015

• Arvinas Secures $41.6 Million Series B Financing - Appoints New Board Members

  10/21/2015

• Arvinas Inks $300 Million Deal With Genentech Over Protein Degradation Technology

  10/2/2015

• Arvinas Appoints Robert Kleinfield As Chief Development Officer

  9/23/2015

• Arvinas Publishes First Peer-Reviewed Paper On Its Proprietary PROTAC Technology

  6/5/2015

• Arvinas Strikes $434 Million Collaboration with Merck & Co. to Continue Thriving in Connecticut

  4/8/2015

• Arvinas Appoints Manuel Litchman As President And Chief Executive Officer

  1/12/2015

• Arvinas Hires Jim Winkler As Chief Scientific Officer

  2/10/2014

• Yale University Spinout Arvinas Lands $18.25 Million to Advance Clinical Programs Focused on Protein Degradation

  9/27/2013